| Literature DB >> 25541060 |
Weilin Wang1, Qingsong Xie2, Xiaohu Zhou2, Jingzi Yao2, Xiaoxiang Zhu2, Pengfei Huang2, Lufei Zhang2, Jianfeng Wei3, Haiyang Xie2, Lin Zhou2, Shusen Zheng4.
Abstract
In previous studies, we confirmed that mitofusin-2 (Mfn2) induced apoptosis in hepatocellular carcinoma (HCC) cells. However, the exact molecular mechanism remained unclear. Mfn2 expressed lower in tumour tissues, compared with adjacent non-cancer tissues. Furthermore, Mfn2 immunostaining was very weak in HCC tissue (P < 0.05) and was significantly associated with tumour size and TNM stage (P = 0.038 and 0.040, respectively), and patients with HCC with lower Mfn2 expression had a poorer prognosis. Overexpression of Mfn2 induced HepG2 cells apoptosis, reduced the mitochondrial membrane potential (ΔΨm) and endoplasmic reticulum (ER) calcium ion (Ca(2+)) concentrations, and elevated intracellular reactive oxygen species (ROS) and mitochondrial Ca(2+) concentrations. However, when HepG2 cells overexpressing Mfn2 were treated with both heparin and RU360, there was no induction of apoptosis, decline in ΔΨm or ER Ca(2+), or increase in intracellular ROS or mitochondrial Ca(2+). We also found downregulation in the expression of mitochondrial calcium uptake1 and 2 (MICU1 and MICU2) in cells transfected with Adv-Mfn2. Thus, we confirmed that Mfn2 induced apoptosis in HCC cells by triggering influx of Ca(2+) into the mitochondria from the ER.Entities:
Keywords: Heparin; InsP(3)R; Mitochondrial Ca(2+) uniporter; Mitochondrial calcium uptake 2; Mitochondrial calcium uptake1; RU360
Mesh:
Substances:
Year: 2014 PMID: 25541060 DOI: 10.1016/j.canlet.2014.12.025
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679